MannKind Corp. CEO Discloses Buying 700K Shares

In a Form 4 filing with the SEC, CEO, 10% Owner of MannKind Corp. (MNKD), discloses buying 700,000 shares of  MNKD on 01/12/2011 at an average price of $8.71 p/sh for a total of $2,800,000.

MannKind Corp has a market cap of $1.12 billion; its shares were trading during Wednesday afternoon trading at around $9.01 with a PEG ratio of (0.10).

Mankind is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer. The co. was founded in 1991 and is based in Valencia, California.

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

About Ron Haruni 1070 Articles
Ron Haruni is the Co-Founder & Editor in Chief of Wall Street Pit.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.